Author's response to letter to the editor

Comment

Baris Deniz. Curr Med Res Opin. 2015 Jan.

. 2015 Jan;31(1):53-5.

doi: 10.1185/03007995.2014.971360. Epub 2014 Oct 24.

No abstract available

Comment on

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
Hutchinson M, Fox RJ, Havrdova E, Kurukulasuriya NC, Sarda SP, Agarwal S, Siddiqui MK, Taneja A, Deniz B. Hutchinson M, et al. Curr Med Res Opin. 2014 Apr;30(4):613-27. doi: 10.1185/03007995.2013.863755. Epub 2013 Nov 26. Curr Med Res Opin. 2014. PMID: 24195574
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27.
Nixon R, Capkun-Niggli G, Bergvall N, Dias S. Nixon R, et al. Curr Med Res Opin. 2015 Jan;31(1):51-2. doi: 10.1185/03007995.2014.971359. Epub 2014 Oct 24. Curr Med Res Opin. 2015. PMID: 25265130 No abstract available.